SCHEMBL710561

SCHEMBL710561

FC(F)(F)C1CCCCC1(C(F)(F)F)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19638396 0.93
SCHEMBL557958 0.85
SCHEMBL9294210 0.73
SCHEMBL30630532 0.73 TRPA1 (0.33)
SCHEMBL8585012 0.71 GAA (0.35)
SCHEMBL21758875 0.71 SLC6A4 (0.30)
SCHEMBL21788188 0.71 SLC6A4 (0.30)
SCHEMBL28322776 0.70
SCHEMBL3749597 0.70
SCHEMBL2687659 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 670 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250381232-A1 BONE DERIVED FIBERS AND OXYGENATED WOUND TREATMENTS TETROUS INC (US) 2025-12-18 US claimed
US-12419916-B2 Bone derived fibers and oxygenated wound treatments TETROUS, INC. (US) 2025-09-23 US claimed
EP-4520312-A2 THERAPEUTIC GAS INFUSED COSMETIC AND METHODS OF INFUSION Tetrous, Inc. (US) 2025-03-12 EP claimed
EP-3664770-B1 THERAPEUTIC GAS INFUSED COSMETIC AND METHODS OF INFUSION TETROUS INC (US) 2024-12-04 EP claimed
CN-111356432-B Cosmetic product for therapeutic gas infusion and method of infusion 特劳斯公司 2024-05-31 CN claimed
US-20230355682-A1 BONE DERIVED FIBERS AND OXYGENATED WOUND TREATMENTS TETROUS, INC. 2023-11-09 US claimed
US-11622979-B2 Bone derived fibers and oxygenated wound treatments TETROUS, INC. (US) 2023-04-11 US claimed
US-20220040237-A1 OXYGENATED DEMINERALIZED BONE MATRIX FOR USE IN BONE GROWTH ISTO TECHNOLOGIES II, LLC 2022-02-10 US claimed
CN-113956851-A Compositions comprising fluoroolefins 科慕埃弗西有限公司 2022-01-21 CN claimed
CN-113943552-A Compositions comprising fluoroolefins 科慕埃弗西有限公司 2022-01-18 CN claimed
US-5536753-A Stable perfluorocarbon and oil emulsions CHILDREN'S HOSPITAL RESEARCH FOUNDATION, A DIVISION OF CHILDREN'S HOSPITAL MEDICAL CENTER AND HEMAGEN/PFC (US) 1996-07-16 US claimed
US-5518731-A Nonaqueous fluorinated drug delivery vehicle suspensions ALLERGAN, INC. (US) 1996-05-21 US claimed
WO-1995031191-A1 USE OF PERFLUOROCARBONS FOR ASSISTING NORMAL BREATHING IN MAMMALS HAVING LUNG DISORDERS SYNTHETIC BLOOD INTERNATIONAL, INC. (US) 1995-11-23 WO claimed
WO-1993018748-A1 COMPOSITIONS COMPRISING A DRUG DELIVERY VEHICLE SUSPENDED IN A NONAQUEOUS FLUORINATED LIQUID ALLERGAN, INC. (US) 1993-09-30 WO claimed
EP-0550615-A1 DRUG DELIVERY VEHICLES SUSPENDED IN NONAQUEOUS PERFLUORINATED CARRIER. ALLERGAN INC (US) 1993-07-14 EP claimed
EP-0231091-B1 STABLE EMULSIONS OF HIGHLY FLUORINATED ORGANIC COMPOUND CHILDREN'S HOSPITAL MEDICAL CENTER (US) 1993-03-31 EP claimed
WO-1992005770-A1 DRUG DELIVERY VEHICLES SUSPENDED IN NONAQUEOUS PERFLUORINATED CARRIER ALLERGAN, INC. (US) 1992-04-16 WO claimed
EP-0231091-A1 Stable emulsions of highly fluorinated organic compound CHILDREN'S HOSPITAL MEDICAL CENTER (US) 1987-08-05 EP claimed
US-4586511-A Methods and compositions for detecting and imaging a gas in an animal by nuclear magnetic resonance CHILDREN'S HOSPITAL MEDICAL CENTER (US) 1986-05-06 US claimed
US-4558279-A Methods for detecting and imaging a temperature of an object by nuclear magnetic resonance UNIVERSITY OF CINCINNATI (US) 1985-12-10 US claimed